Show simple item record

dc.contributor.authorDoshi, Peter
dc.date.accessioned2021-12-16T15:08:16Z
dc.date.available2021-12-16T15:08:16Z
dc.date.issued2021-01-04
dc.identifier.urihttp://hdl.handle.net/10713/17411
dc.descriptionOn 5 February 2021 BMJ published a clarification to this piece at https://blogs.bmj.com/bmj/2021/02/05/clarification-pfizer-and-modernas-95-effective-vaccines-we-need-more-details-and-the-raw-data/.en_US
dc.description.urihttps://blogs.bmj.com/bmj/2021/01/04/peter-doshi-pfizer-and-modernas-95-effective-vaccines-we-need-more-details-and-the-raw-data/en_US
dc.description.urihttps://blogs.bmj.com/bmj/2021/02/05/clarification-pfizer-and-modernas-95-effective-vaccines-we-need-more-details-and-the-raw-data/en_US
dc.language.isoen_USen_US
dc.publisherBMJ Publishing Groupen_US
dc.relation.ispartofThe BMJ Opinionen_US
dc.subjectdata transparencyen_US
dc.subjectraw dataen_US
dc.subject.meshCOVID-19 Vaccinesen_US
dc.subject.meshVaccine Efficacyen_US
dc.subject.meshCOVID-19 Nucleic Acid Testingen_US
dc.titlePeter Doshi: Pfizer and Moderna’s “95% effective” vaccines—we need more details and the raw dataen_US
dc.typeBlogen_US


This item appears in the following Collection(s)

Show simple item record